
David J. Blanchard
Supervisory Patent Examiner (ID: 12250, Phone: (571)272-0827 , Office: P/1619 )
| Most Active Art Unit | 1643 |
| Art Unit(s) | 1619, 1643, 1642 |
| Total Applications | 551 |
| Issued Applications | 169 |
| Pending Applications | 112 |
| Abandoned Applications | 273 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6658320
[patent_doc_number] => 20030133939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-17
[patent_title] => 'Binding domain-immunoglobulin fusion proteins'
[patent_app_type] => new
[patent_app_number] => 10/053530
[patent_app_country] => US
[patent_app_date] => 2002-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 26762
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 232
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0133/20030133939.pdf
[firstpage_image] =>[orig_patent_app_number] => 10053530
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/053530 | Binding domain-immunoglobulin fusion proteins | Jan 16, 2002 | Abandoned |
Array
(
[id] => 6801178
[patent_doc_number] => 20030096343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-22
[patent_title] => 'Modular assembly of antibody genes, antibodies prepared thereby and use'
[patent_app_type] => new
[patent_app_number] => 10/040945
[patent_app_country] => US
[patent_app_date] => 2002-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 61
[patent_figures_cnt] => 61
[patent_no_of_words] => 34577
[patent_no_of_claims] => 94
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20030096343.pdf
[firstpage_image] =>[orig_patent_app_number] => 10040945
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/040945 | Modular assembly of antibody genes, antibodies prepared thereby and use | Jan 8, 2002 | Abandoned |
Array
(
[id] => 7226851
[patent_doc_number] => 20040073011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-15
[patent_title] => 'Specific human antibodies for selective cancer therapy'
[patent_app_type] => new
[patent_app_number] => 10/029926
[patent_app_country] => US
[patent_app_date] => 2001-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 32570
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20040073011.pdf
[firstpage_image] =>[orig_patent_app_number] => 10029926
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/029926 | Specific human antibodies for selective cancer therapy | Dec 30, 2001 | Issued |
Array
(
[id] => 6861885
[patent_doc_number] => 20030092893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Secreted protein HEMAE80'
[patent_app_type] => new
[patent_app_number] => 10/023282
[patent_app_country] => US
[patent_app_date] => 2001-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 159533
[patent_no_of_claims] => 75
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20030092893.pdf
[firstpage_image] =>[orig_patent_app_number] => 10023282
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/023282 | Secreted protein HEMAE80 | Dec 19, 2001 | Abandoned |
Array
(
[id] => 6276019
[patent_doc_number] => 20020106685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'Method for specifically detecting tumor cells and their precursors in uterine cervical smears by simultaneously measuring at least 2 different molecular markers'
[patent_app_type] => new
[patent_app_number] => 10/022618
[patent_app_country] => US
[patent_app_date] => 2001-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5591
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20020106685.pdf
[firstpage_image] =>[orig_patent_app_number] => 10022618
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/022618 | Method for specifically detecting tumor cells and their precursors in uterine cervical smears by simultaneously measuring at least 2 different molecular markers | Dec 16, 2001 | Abandoned |
Array
(
[id] => 556514
[patent_doc_number] => 07160985
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-09
[patent_title] => 'Pro180 polypeptide'
[patent_app_type] => utility
[patent_app_number] => 10/006867
[patent_app_country] => US
[patent_app_date] => 2001-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 168
[patent_figures_cnt] => 168
[patent_no_of_words] => 44454
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/160/07160985.pdf
[firstpage_image] =>[orig_patent_app_number] => 10006867
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/006867 | Pro180 polypeptide | Dec 5, 2001 | Issued |
Array
(
[id] => 738026
[patent_doc_number] => 07034136
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-25
[patent_title] => 'Nucleic acids encoding PRO1159 polypeptides'
[patent_app_type] => utility
[patent_app_number] => 09/989293
[patent_app_country] => US
[patent_app_date] => 2001-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 330
[patent_figures_cnt] => 330
[patent_no_of_words] => 286984
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/034/07034136.pdf
[firstpage_image] =>[orig_patent_app_number] => 09989293
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/989293 | Nucleic acids encoding PRO1159 polypeptides | Nov 19, 2001 | Issued |
Array
(
[id] => 6774138
[patent_doc_number] => 20030017476
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-23
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/989724
[patent_app_country] => US
[patent_app_date] => 2001-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 331
[patent_figures_cnt] => 331
[patent_no_of_words] => 290967
[patent_no_of_claims] => 118
[patent_no_of_ind_claims] => 42
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0017/20030017476.pdf
[firstpage_image] =>[orig_patent_app_number] => 09989724
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/989724 | PRO1312 nucleic acids | Nov 19, 2001 | Issued |
Array
(
[id] => 6674229
[patent_doc_number] => 20030059832
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-27
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/997349
[patent_app_country] => US
[patent_app_date] => 2001-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 331
[patent_figures_cnt] => 331
[patent_no_of_words] => 291063
[patent_no_of_claims] => 118
[patent_no_of_ind_claims] => 42
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20030059832.pdf
[firstpage_image] =>[orig_patent_app_number] => 09997349
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/997349 | Pro1159 polypeptides | Nov 14, 2001 | Issued |
Array
(
[id] => 737967
[patent_doc_number] => 07034122
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-04-25
[patent_title] => 'Antibodies to PRO1159 polypeptides'
[patent_app_type] => utility
[patent_app_number] => 09/997653
[patent_app_country] => US
[patent_app_date] => 2001-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 330
[patent_figures_cnt] => 330
[patent_no_of_words] => 286831
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/034/07034122.pdf
[firstpage_image] =>[orig_patent_app_number] => 09997653
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/997653 | Antibodies to PRO1159 polypeptides | Nov 14, 2001 | Issued |
Array
(
[id] => 651079
[patent_doc_number] => 07112656
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-26
[patent_title] => 'PRO1312 polypeptides'
[patent_app_type] => utility
[patent_app_number] => 09/997641
[patent_app_country] => US
[patent_app_date] => 2001-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 330
[patent_figures_cnt] => 330
[patent_no_of_words] => 282762
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/112/07112656.pdf
[firstpage_image] =>[orig_patent_app_number] => 09997641
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/997641 | PRO1312 polypeptides | Nov 14, 2001 | Issued |
Array
(
[id] => 520198
[patent_doc_number] => 07189824
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-13
[patent_title] => 'Tumor vessel endothelial cell-binding monoclonal antibodies'
[patent_app_type] => utility
[patent_app_number] => 10/012271
[patent_app_country] => US
[patent_app_date] => 2001-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7424
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/189/07189824.pdf
[firstpage_image] =>[orig_patent_app_number] => 10012271
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/012271 | Tumor vessel endothelial cell-binding monoclonal antibodies | Nov 7, 2001 | Issued |
Array
(
[id] => 6865547
[patent_doc_number] => 20030191073
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer'
[patent_app_type] => new
[patent_app_number] => 10/005480
[patent_app_country] => US
[patent_app_date] => 2001-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 74527
[patent_no_of_claims] => 77
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20030191073.pdf
[firstpage_image] =>[orig_patent_app_number] => 10005480
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/005480 | Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer | Nov 6, 2001 | Abandoned |
Array
(
[id] => 6716652
[patent_doc_number] => 20030028000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-02-06
[patent_title] => 'CYP1B1 nucleic acids and methods of use'
[patent_app_type] => new
[patent_app_number] => 09/999686
[patent_app_country] => US
[patent_app_date] => 2001-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 16751
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20030028000.pdf
[firstpage_image] =>[orig_patent_app_number] => 09999686
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/999686 | CYP1B1 nucleic acids and methods of use | Oct 30, 2001 | Issued |
Array
(
[id] => 6782965
[patent_doc_number] => 20030064412
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-03
[patent_title] => '123 human secreted proteins'
[patent_app_type] => new
[patent_app_number] => 09/984490
[patent_app_country] => US
[patent_app_date] => 2001-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 108279
[patent_no_of_claims] => 70
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20030064412.pdf
[firstpage_image] =>[orig_patent_app_number] => 09984490
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/984490 | 123 human secreted proteins | Oct 29, 2001 | Abandoned |
Array
(
[id] => 6664076
[patent_doc_number] => 20030203402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-30
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/017084
[patent_app_country] => US
[patent_app_date] => 2001-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 238
[patent_figures_cnt] => 238
[patent_no_of_words] => 192189
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20030203402.pdf
[firstpage_image] =>[orig_patent_app_number] => 10017084
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/017084 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Oct 23, 2001 | Abandoned |
| 09/959276 | Proliferation inhibitor for androgen-independent tumor | Oct 18, 2001 | Abandoned |
Array
(
[id] => 6684180
[patent_doc_number] => 20030120044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Methods of optimizing antibody variable region binding affinity'
[patent_app_type] => new
[patent_app_number] => 09/982464
[patent_app_country] => US
[patent_app_date] => 2001-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16128
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 263
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20030120044.pdf
[firstpage_image] =>[orig_patent_app_number] => 09982464
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/982464 | Methods of optimizing antibody variable region binding affinity | Oct 17, 2001 | Abandoned |
Array
(
[id] => 6809497
[patent_doc_number] => 20030199436
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-23
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/978544
[patent_app_country] => US
[patent_app_date] => 2001-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 238
[patent_figures_cnt] => 238
[patent_no_of_words] => 192099
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20030199436.pdf
[firstpage_image] =>[orig_patent_app_number] => 09978544
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/978544 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Oct 15, 2001 | Abandoned |
Array
(
[id] => 6721297
[patent_doc_number] => 20030054986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-20
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/981915
[patent_app_country] => US
[patent_app_date] => 2001-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 238
[patent_figures_cnt] => 238
[patent_no_of_words] => 194052
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20030054986.pdf
[firstpage_image] =>[orig_patent_app_number] => 09981915
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/981915 | PRO337 polypeptides | Oct 15, 2001 | Issued |